The potential of residual clinical Group B Streptococcus swabs for assessing the vaginorectal microbiome in late pregnancy

TL;DR

This study shows that leftover swabs used for Group B Streptococcus screening in late pregnancy can reliably provide data on the maternal microbiome, offering a practical way to study pregnancy health outcomes.

Contribution

The study demonstrates that residual clinical swabs can be used for microbiome research without additional sampling, enabling large-scale pregnancy studies.

Findings

Residual clinical swabs stored at 4°C for 7–10 days retained microbiome profiles consistent with published studies.

Research swabs stored at 4°C showed minimal microbiota changes over ten days, unlike those stored at room temperature.

Residual clinical swabs are a reliable source for studying the late pregnancy microbiome.

Abstract

The maternal pregnancy microbiome (including genitourinary and gut) has been linked to important pregnancy/birth and later childhood health outcomes. However, such sampling as part of large population cohort studies is logistically and financially challenging. Many countries routinely collect vaginal or vaginal-rectal swabs in late pregnancy for Group B Streptococcus (GBS) screening, but their utility for population-based research is still unclear. As part of planning for the Generation Victoria population-based cohort study beginning in pregnancy, we assessed the utility and reliability of residual clinical GBS vaginal/vaginal-rectal swabs for generating late pregnancy microbiome data. We carried out a two-phased pilot study. Phase one assessed the level of microbial diversity apparent in ‘residual’ clinical vaginal/vaginal-rectal swabs post clinical testing and storage for 7–10 days at 4 °C (routine clinical practice). Phase two directly assessed the impact of storage time and temperature on the microbial composition of vaginal/vaginal-rectal swabs collected specifically for research purposes. The microbiota composition in the ‘residual’ clinical swabs aligned with published studies. The ‘research’ swabs, stored at 4 °C for up to ten days, showed minimal changes in microbiota profile, compared to swabs examined on the day of collection. In contrast, significant variation in diversity was seen in swabs stored at room temperature for up to 48 h. Residual clinical material from swabs collected primarily for GBS screening in late pregnancy represent a reliable and abundant source of material for assessing the late pregnancy maternal microbiome for research purposes. This represents a low-burden opportunity for population-representative pregnancy studies to assess the potential of late pregnancy microbiome for prediction and understanding maternal and child health outcomes.

Figures